Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
100,740,741
-
Number of holders
-
93
-
Total 13F shares, excl. options
-
24,227,264
-
Shares change
-
+9,063,718
-
Total reported value, excl. options
-
$569,258,893
-
Value change
-
+$191,161,902
-
Put/Call ratio
-
71.21%
-
Number of buys
-
80
-
Number of sells
-
-18
-
Price
-
$23.5
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q2 2015
105 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q2 2015.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24,227,264 shares
of 100,740,741 outstanding shares and own 24.05% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP LLC (2,527,386 shares), VANGUARD GROUP INC (2,467,714 shares), WADDELL & REED FINANCIAL INC (2,030,012 shares), FRANKLIN RESOURCES INC (1,742,176 shares), JPMORGAN CHASE & CO (1,603,332 shares), Visium Asset Management, LP (1,570,141 shares), JANUS CAPITAL MANAGEMENT LLC (1,390,366 shares), EcoR1 Capital, LLC (1,205,391 shares), BlackRock Fund Advisors (1,140,004 shares), and PRICE T ROWE ASSOCIATES INC /MD/ (934,036 shares).
This table shows the top 93 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.